Stanford Health Care said on Thursday that it would have a new chief of cardiac surgery after a board appointed by the US surgeon general recommended it as the preferred surgeon for cardiac surgeries, and that the new CEO would be chief of cardiothoracic surgery.
Stanford’s move comes after a survey from the American Heart Association found that only about 3% of doctors would take more risks in the rest, with the vast majority doing so for their own benefit.
In a statement, Stanford Health said the board appointed in January was made up of surgeons from around the country and that it has a long history of leading the way in medical innovation and quality care.
The board recommended Dr. Michael M. DeAngelis for chief of coronary surgery and Dr. Mark D. Johnson for chief cardiology.
The move comes as many states have enacted laws requiring cardiologists to be licensed, a step that has drawn criticism from some medical ethicists who believe licensing is unnecessary and would put the health care profession in jeopardy.
California’s Board of Cardiac Surgeons has recommended that all cardiographic surgeons must be licensed.
The University of California at San Francisco, which has led the way on licensing reforms, also released a statement Thursday saying that the board had voted unanimously to appoint DeAngelides as chief cardiologist, a position he would hold until a successor is named.
Johnson will be the first chief cardiographer to serve in a position with more than one doctor.
Stanfield will continue to work closely with the university’s cardiac care center and clinical research facilities to provide cardiac surgery services to the community, said Mark R. Grosen, vice president for public affairs at Stanford.
“We are committed to working collaboratively with our academic community and the academic community at large,” he said.
“Our goal is to ensure the highest quality care is provided to our patients.”
Stanford said it will also create a new cardiac surgeon team to focus on advanced medical care, such as the design of new technology, the delivery of new therapies and procedures, and the development of innovative patient-centered care and services.
Stanley, a public university in Palo Alto, California, was founded in 1892 and has about 1,600 faculty members.